Organization | Cantonal Hospital Winterthur

Cantonal Hospital Winterthur Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Winterthur Switzerland (1876)

Organization Overview

First Clinical Trial

2001

NCT00030771

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Cantonal Hospital Winterthur, Department of Surgery | Kantonsspital Winterthur KSW

Active Ingredients

Drugs in Phase 4 Trials (1)

desflurane (suprane) (1 trial)

Drugs in Phase 3 Trials (4)

cisplatin (platinol) (2 trials)

denosumab (prolia) (1 trial)

docetaxel (taxotere) (2 trials)

progesterone (progestasert) (1 trial)

Drugs in Phase 2 Trials (5)

carboplatin (paraplatin) (1 trial)

cetuximab (erbitux) (1 trial)

lurbinectedin (Zepzelca) (1 trial)

paclitaxel (taxol) (1 trial)

vadimezan (1 trial)

Drugs in Other Trials (3)

clobetasol (dermovate) (1 trial)

oxygen (1 trial)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 3)

Mesothelioma (Phase 2)

Neoplasm Metastasis (Phase 3)

Neoplastic Cells, Circulating (Phase 4)

Obstetric Labor, Premature (Phase 3)

Pancreatic Neoplasms (Phase 4)

Perinatal Death (Phase 3)

Premature Birth (Phase 3)

Prostatic Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 11
# of Trial APIs: 13